OncoSec Medical Inc (ONCSQ)

[trading.jeff]

OncoSec Announces that Shareholders Have Approved CGP/Sirtex Transaction

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that, at its Special Meeting of Shareholders (the “Special Meeting”), based on a preliminary vote count provided by the Company’s proxy solicitor, OncoSec shareholders have approved the proposed strategic investment by and partnership (the “CGP/Sirtex Transaction”) with Grand Decade Developments Limited, a wholly owned subsidiary of China Grand Pharmaceutical and Healthcare Holdings Limited (“CGP”), and its U.S. affiliate, Sirtex Medical US Holdings, Inc. (“Sirtex”).

Daniel J. O’Connor, President and Chief Executive Officer of OncoSec, said, “I personally would like to thank all of our shareholders for making their voices heard at this Special Meeting and for their support for the CGP/Sirtex Transaction. This Transaction marks the start of a collaboration with CGP and Sirtex, two powerful drug development companies, which we expect will flourish over time. It also provides OncoSec much needed capital to continue our ongoing and future clinical trials. We are excited to put this proxy contest behind us and now throttle up our development of effective treatments for cancer patients.”

The Company will file final voting results on a Form 8-K following certification by the Inspector of Elections.

https://ih.advfn.com/stock-market/NASDAQ/oncosec-medical-ONCS/stock-news/81701642/oncosec-announces-that-shareholders-have-approved

$ONCS